Trial Profile
Phase I trial of Gimeracil/oteracil/tegafur (S-1) as a preoperative chemoradiation therapy in patients with low rectal cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Rectal cancer
- Focus Adverse reactions
- 26 Nov 2015 New trial record